首页>投融资

ElevateBio

D轮

ElevateBio LLC is a company focused on the development of transformative cell and gene therapies.In October 2021, ElevateBio LLC acquired all of AgBiome Delta LLC’s shares of Life Edit Therapeutics Inc.In June 2021, Boston Children’s Hospital and ElevateBio had entered into a five-year collaborative agreement.In May 2023, ElevateBio LLC closed its $401 million Series D financing.In March 2020, ElevateBio completed a $170-million Series B financing

https://www.elevate.bio/

470181

基本信息

公司全称

ElevateBio LLC
类型

细胞和基因治疗新药研发商
产业领域

药品研发/制造、生物药、生物药
公司人数

15~50人
地址

139 Main Street,Suite 500 CAMBRIDGE MASSACHUSETTS 02142; US; Telephone: +16174332605;
联系电话

617-433-2600
邮箱

info@elevate.bio
成立时间

2017-11-29

投融资

2023-05-24

D轮

4.01亿美元

Redmile Group

EcoR1 Capital

Surveyor Capital

Lee Family Office

ITOCHU Corporation

AyurMaya Capital Management Fund
2021-03-15

C轮

5.25亿美元

Samsara BioCapital

Invus

Vertex Ventures

Emerson Collective

MPM Capital

EcoR1 Capital

ITOCHU Corporation

软银愿景基金

新加坡经济发展局投资

Redmile Group

富达国际

F2 Ventures

Matrix Capital Management

Surveyor Capital
2020-03-30

B轮

1.7亿美元

Samsara BioCapital

Invus

Vertex Ventures

MPM Capital

EcoR1 Capital

新加坡经济发展局投资

Redmile Group

F2 Ventures

Surveyor Capital
2019-05-13

A轮

1.5亿美元

Samsara BioCapital

UBS Oncology Impact Fund

Redmile Group

EcoR1 Capital
加载更多

ElevateBio

基本信息

投融资

相关投融资企业